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Summary
In a prospective study of 256 postoperative patients, bilateral
lower limb venography was performed using meglumine
iothalamate followed by heparin-saline flushing of the deep
veins, and the complications of the procedure were assessed.
No patient developed clinical evidence of deep-vein throm-
bosis after the venogram. In 117 patients fibrinogen uptake
was performed 24 hours after the venogram. A new positive
area on the uptake scan developed in 3 patients (2,6%).
Local swelling or haematoma at the injection site occurred
in 15 patients (5,9%), cellulitis in 2 (0,8%) and minor contrast
reactions in 6 (2,3%). There were no major reactions and no
procedure-related mortality.
The reasons for the wide variation in the reported incidence
of post-venogram thrombosis are considered and the impor-
tance of heparin-saline f1ustiing of the deep veins to prevent
this complication is discussed.
S AIr Med J 1991; 79: 88-89.
The symptoms and signs of lower limb deep-vein thrombosis
(DVT) are notoriously nonspecific. 1•2 An incorrect clinical
diagnosis, will result in inappropriate therapy with the anen-
dant risk and cost of unnecessary anticoagulation. A clitJ.ically
suspected DVT should be confirmed with an objective inves-
tigation.
Venography has a high sensitivity and specificity in the
diagnosis of DVT and represents the reference standard against
which other tests are compared. However, the perceived com-
plications of venography, panicularly venogram-induced DVT,
have militated against its use. 3 The alternative non-invasive
tests, which include Doppler ultrasound, impedance plethys-
mography and the 1251 fibrinogen uptake test, are less accurate
than venography. If post-venogram complications could be
reduced to acceptable levels the accuracy of venography would
outweigh its disadvantages.
Patients and methods
During the period 1975-1984, 256 patients aged over 40 years,
who compromised the control limb of a randomised study,
underwent bilateral lower limb venography after major abdo-
minal surgery. The design of the study allowed for critical
evaluation of the methods and complications of venography.4
None of these patients had received anticoagulants before the
venogram.
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On the day before surgery, 100 jlCi 125I-labelled fibrinogen
(Amersham, England) was injected intravenously, after thyroid
blockade with sodium iodide. The count rate at fixed points on
the legs was recorded pre-operatively and at daily intervals
postoperatively using a ponable ratemeter. A 20% rise in
count, persistent for 48 hours or more, was regarded as a
positive result. 5 If the central count levels dropped, I251 fibri-
nogen was re-injected.
On the 6th postoperative day, bilateral ascending venography
was performed using meglumine iothalamate (Conray 280).
Fibrinogen uptake counts were done on 2 or more days after
the venogram in 117 patients.
The method of venography was adapted from that described
by Rabinov and Paulin.6 The patient was placed in a semi-
erect position with the contralateral foot weight-bearing, allow-
ing the leg being examined to hang free. A 21-gauge bunerfly
needle was introduced into a suitable vein on the dorsum of
the foot, a small amount of heparinised saline injected to
establish patency and ensure against extravasation; and then
the contrast medium injected under fluoroscopic' control. SerIal
spot films were taken as far as the iliac veins, applying gentle
calf pressure to move the contrast up the veins. The final
exposures of the iliac veins and the inferior vena cava were
taken after moving the screening table to the horizontal- posi-
tion. Usually 8 - 10 exposures were needed for the examination
and 75 - 100 ml contrast material per limb was injected. .
A tourniquet was not used during the examination. During
the injection of contrast medium a light was kept focused on
the injection site, observing for signs of extravasation. At the
end of the examination 1000 IU heparin diluted in 50 ml
saline was injected to flush the contrast material from the deep
vems.
The diagnosis of DVT was based on the presence of filling
defects, abrupt termination of contrast-filled veins or non-
filling of all or pan of the deep system with collateral flow.
The normal anatomy of the deep veins and the diagnostic
pitfalls have been well described by Lea Thomas.7
Results
Venography demonstrated DVT in 20,8% of patients. In
approximately half the cases it was bilateral and in most it was
restricted to the calf. .
Swelling or bruising at the injection site was noted in 15
patients (5,9%). In most cases this was asymptomatic, but a
few patients complained of local pain. Cellulitis developed in 2
patients (0,8%) and minor contrast reactions, including dizzi-
ness, vomiting, unicaria, peri-orbital swelling and hroncho-
spasm, occurred in 6 (2,3%). There were no major reactions
and no procedure-related deaths.
In 3 patients venography was performed on one side only.
Two of these patients vomited after the i.njection into the first
limb and in one no suitable vein was found. None of the
patients had clinical evidence of DVT after the venograin.
Radio-active fibrinogen uptake studies were continued for at
least 24 hours after the venogram in 117 patients. Positive
uptakes were recorded in 9 patients (9 legs). Six of these had
already shown evidence of superficial or DVT on the veno-
gram. Thus 3 patients (3 legs) developed a new posltlve
fibrinogen uptake scan after the venogram (2,6% of patients,
1,3% oflegs).
Discussion
Controversy still exists with regard to venography with ionic
contrast media, some writers being of the opinion that the
thrombotic complications are sufficiently severe to warrant the
routine use of non-ionic materials despite very high costS or
abandoning venography for the routine diagnosis of suspected
DVT.3
Venous thrombosis as a complication of venography has
been reponed as occurring in up to 50% of patients.9 Benman
and Paulin 10 observed that 32% of patients developed erythe-
matous swelling of the lower limb 12 ,. 24 hours after negative
venography using meglumine ditrizoate (Renografin).lO They
termed this a 'contrast-related inflammatory response' and
postulated that it was due to contrast-related endothelial
damage, and possibly even thrombophlebitis in some patients.
More recent series have anempted to define the prevalence
of post-venographic DVT with the use of the 1251 fibrinogen
uptake test. A number of studies using ionic contrast materials
have recorded high uptakes in the lower le~, interpreted as
representing DVT in 7 - 55% of patients.B•• 11-13 The inter-
pretation of these findings is far from straightforward. Factors
that may influence the wide variation in reponed incidence
include the criteria of positivity for the fibrinogen uptake test,
the underlying disorder dictating the need for venography, the
venographic technique, the contrast material used and the
concomitant use of anticoagulants. The 1251 fibrinogen test
lacks specificity for the diagnosis of DVT. Local high uptakes
may be demonstrated in any condition in which fibrin is
deposited, such as superficial vein thrombosis, oedema, cellu-
litis and haematoma. It is tempting to speculate that transient
contrast-induced damage to the venous wall or endothelium
and not necessarily venous thrombosis may be the cause of a
proportion of elevated fibrinogen counts. Most patients who
develop a positive scan after venography do so in the first
48 -72 hours and the majority of high counts are concentrated
in the ankle region. I I Venography may therefore induce a
chemical phlebitis or periphlebitis that mayor may not be
associated with thrombosis.
The only method currently available to elucid'ate the precise
significance of a positive post-venogram scan is a repeat veno-
gram. This is impractical and probably unethical. Albrechtson
and Olsson 12 reponed the development of a positive fibrinogen
uptake in 20 of 61 patients who had an initially normal
venogram. A second venogram was performed in 4 cases and
fresh thrombus shown in 2. Ritchie er al. ll reponed deve-
lopment of a positive scan in 30 of 55 limbs (55%) after
venography, with the majority of high counts restricted to the
ankle region; 3 patients became symptomatic with raised counts
above the level of the knee, and thrombosis was confirmed in 2
of them, who were submined to repeat venography. ·The
remaining 27 limbs remained asymptomatic.
Comparisons between ionic and non-ionic contrast materials
with respect to contrast-related complications have been
reported. Using the 1251 fibrinogen uptake test, Walters er al.B
found a positive result in 28,6% of limbs after an ionic contrast
material (Conray 280) and 3,6% of limbs after a non-ionic one
(metrizamide). Similar results were reported by Lea Thomas
er al. 13 with a 26,7% incidence after Conray 280 and 3,3% after
Hexabrix. 13 The results in these studies were not confirmed
venographically.
The low incidence of raised fibrinogen counts in our study
may be due to the techniques employed. Firstly, a tourniquet
was not used to direct the contrast medium to the deep veins,
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reducing the. pressure as well as the contact time of the
contrast with the vessel wall, and secondly, after the procedure
heparin in saline (1 000 IU 50 ml) was used to flush the deep
veins with screening of the limbs to ensure that no residual
centrast remained.
Little mention of the heparin saline flush has been made in
the literature and it does not appear to be widely practised.
The first study l4 mentioning its use was published in 1979 and
noted that the incidence of clinically diagnosed post-venogram
thrombophlebitis was reduced from 4,4% to 2% using 1000 IU
heparin in 250 ml 5% dextrose as an infusion into the limb. A
second studyl5 reported an incidence of post-venogram DVT
of only 3,3% diagnosed on fibrinogen uptake after a flush of
10000 IU heparin. In both these studies ionic contrast media
were used. It should be noted, however, that neither of these
two studies was randomised. Furthermore, the claimed reduc-
tion in thrombophlebitis after venography anributed to heparin
saline flush by Arndt er al. 14 is not statistically significant
when their data are recalculated (P = 0,38; chi-square test
with Yates's correction). Heparin in high concentration may in
fact injure venous endothelium close to the site of injection, as
demonstrated in an animal model by Franz and his colleagues. 16
Ideally our study should have been randomised to a saline
versus a heparin saline completion flush. It is conceivable but
unproven that the mere mechanical clearance of contrast is as
beneficial as the addition of heparin. Our goal, however, was
not specifically to examine the use of a heparin saline flush but
to audit the morbidity of an established venographic technique
in our institution. In this regard the incidence of complications
we recorded compares favourably with the incidence in studies
using non-ionic contrast materials. This would suggest that
the cheaper ionic contrast materials can be used with acceptably
low morbidity provided a careful technique is followed.
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